Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Institut National de la Santé Et de la Recherche Médicale, France | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Chronic pain is an extremely disabling disease. It is a major public health problem due to the lack of effective therapy.
Chronic postoperative pain (CPOP) is defined by a painful symptomatology in the operated area unrelated to previous pain, present for more than 3 months, and without any link to surgical complication.
The prevalence of chronicization of postoperative pain is 30% after total knee arthroplasty.
Identification of clinical, biological and psychological profiles are crucial to prevent CPOP.
A biologic factor, Brain Derived Neurotrophic Factor (BDNF) produced by a variety of cells is a key regulator of neuroplasticity. BDNF is increasingly studied in the mechanisms of cerebral sensitization and pain chronicization. The role of BDNF in pain of patients remains to be explored in a prospective study. The aim of this observational study is to compare the kinetics of BDNF after total knee arthroplasty in patients with and without CPOP.
Patients will be included in the study at the preanesthetic consultation. Serum BDNF levels will be measured preoperatively, 48h postoperatively, 3 and 6 months after surgery.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Total knee arthroplasty | Other | patient operated for a total knee arthroplasty |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| blood test | Diagnostic Test | blood test to explore BDNF level |
|
| Measure | Description | Time Frame |
|---|---|---|
| BDNF level | assessed by ELISA technique | preoperative to 6 months after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| Pain level | evaluated by Visual Analog Scale (VAS) | preoperative to 6 months after surgery |
| Neuropathic pain diagnostic | evaluated by neuropathic pain diagnostic questionnaire (DN4) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Anesthesiology and critical care, Lapeyronie University Hospital | Montpellier | 34295 | France |
Not provided
| ID | Term |
|---|---|
| D010149 | Pain, Postoperative |
| ID | Term |
|---|---|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010146 | Pain |
Not provided
Not provided
| ID | Term |
|---|---|
| D006403 | Hematologic Tests |
| ID | Term |
|---|---|
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D008919 | Investigative Techniques |
Not provided
Not provided
Prospective study to analyze perioperative blood samples in patient after knee replacement surgery. Patients will be included in the study at the pre-anesthetic consultation. Serum BDNF levels will be measured preoperatively, 48h postoperatively, 3 and 6 months after surgery.
Not provided
Not provided
Not provided
Not provided
| preoperative to 6 months after surgery |
| Postoperative rehabilitation | evaluated by the Brief Pain Questionary (BPI) | preoperative to 6 months after surgery |
| Health related quality of life | evaluated by the SF-12 Health Survey | preoperative to 6 months after surgery |
| Anxiety and Depression | evaluated by the Hospital Anxiety and Depression scale (HAD) | preoperative to 6 months after surgery |
| Pain level perception | evaluated by the The pain Catastrophizing Scale | preoperative to 6 months after surgery |
| Assessment of functional capacities in knee arthritis | evaluated by the Western Ontario and McMaster Universities Arthritis Index (WOMAC) | preoperative to 6 months after surgery |
| Oxidative stress marker | 8-iso-prostaglandin F2α level by biochemical labeling | preoperative to 6 months after surgery |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |